Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125661351 | 12566135 | 1 | I | 2016 | 20160711 | 20160718 | 20160718 | EXP | US-PFIZER INC-2016341727 | PFIZER | 71.00 | YR | F | Y | 0.00000 | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125661351 | 12566135 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 3X/DAY | A563501 | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||
| 125661351 | 12566135 | 2 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 40 MG, 1X/DAY | 0 | 40 | MG | QD | ||||||||
| 125661351 | 12566135 | 3 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 125661351 | 12566135 | 4 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | 25 MG, AS NEEDED | 0 | 25 | MG | |||||||||
| 125661351 | 12566135 | 5 | C | TRAMADOL. | TRAMADOL | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 125661351 | 12566135 | 6 | C | BABY ASPIRIN | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | |||||||||
| 125661351 | 12566135 | 7 | C | LETAIRIS | AMBRISENTAN | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 125661351 | 12566135 | 8 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 25 MG, 2X/DAY | 0 | 25 | MG | BID | ||||||||
| 125661351 | 12566135 | 9 | C | BUMETANIDE. | BUMETANIDE | 1 | 1 MG, 2X/DAY | 0 | 1 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125661351 | 12566135 | 1 | Pulmonary hypertension |
| 125661351 | 12566135 | 2 | Abdominal discomfort |
| 125661351 | 12566135 | 3 | Gastric disorder |
| 125661351 | 12566135 | 4 | Blood pressure abnormal |
| 125661351 | 12566135 | 5 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125661351 | 12566135 | HO |
| 125661351 | 12566135 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125661351 | 12566135 | Abdominal pain | |
| 125661351 | 12566135 | Chest pain | |
| 125661351 | 12566135 | Pneumonia | |
| 125661351 | 12566135 | Pulmonary oedema | |
| 125661351 | 12566135 | Renal impairment | |
| 125661351 | 12566135 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |